Suchergebnisse - "Holzmayer, Vera"

PubPharm (14)

1

The diversification of SARS-CoV-2 Omicron variants and evaluation of their detection with molecular and rapid antigen assays

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2023

von Anderson, M. | Holzmayer, V. | Harris, B. | +9

2

Modified ARCHITECT® serologic assays enable plasma-level performance from dried blood spot samples

enthalten in: BioTechniques | 2022

von Holzmayer, V. | Anderson, M. | Ndembi, N. | +3

3

HBsAg isoform dynamics during NAP-based therapy of HBeAg-negative chronic HBV and HBV/HDV infection

enthalten in: Hepatology communications | 2022

von Bazinet, M. | Anderson, M. | Pântea, V. | +15

4

Hepatitis B surface antigen and hepatitis B RNA changes in HIV/hepatitis B virus co-infected participants receiving hepatitis B virus-active antiretroviral therapy

enthalten in: AIDS (London, England) | 2022

von Hawkins, C. | Kang, M. | Bhattacharya, D. | +15

5

More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replication

enthalten in: Scientific reports | 2021

von Luk, K. | Gersch, J. | Harris, B. | +5

6

Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP-Based Therapy

enthalten in: Hepatology communications | 2021

von Bazinet, M. | Anderson, M. | Pântea, V. | +15

7

Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2021

von Anderson, M. | Holzmayer, V. | Vallari, A. | +3

8

Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139-Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection

enthalten in: Hepatology communications | 2021

von Bazinet, M. | Pântea, V. | Cebotarescu, V. | +11

9

Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg)

enthalten in: Alimentary pharmacology & therapeutics | 2021

von Lim, S. | Phyo, W. | Ling, J. | +20

CommentIn: Aliment Pharmacol Ther. 2021 Jan;53(2):332-333. - PMID 33368512

10

Early emergence of anti-HCV antibody implicates donor origin in recipients of an HCV-infected organ

enthalten in: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | 2019

von Porrett, P. | Reese, P. | Holzmayer, V. | +14